https://www.businesswire.com/news/home/20240327454257/en/Aldeyra-Therapeutics-Announces-Clinical-Development-Plan-for-Resubmission-of-New-Drug-Application-for-Reproxalap-in-Dry-Eye-Disease
Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat imm...
clinical development plan